Reckitt Benckiser on Friday made an offer to acquire all of the outstanding shares of VMS maker Schiff Nutrition for $42 per share in cash, or approximately $1.4 billion — a premium of 23.5% more than the $34 per share offer Bayer HealthCare announced Oct. 30.
The launch of a tamper-resistant formulation of a popular opioid painkiller in the United States, but not in Canada, may have influenced a spike in dispensing rate of the original at pharmacies in Canadian border cities, according to a study.
Recent research from the Rothman Institute at Jefferson has shown aspirin to be just as effective in preventing clots — specifically pulmonary emboli, life-threatening blood clots that can develop in the arteries of the lungs following joint replacement surgery — Thomas Jefferson University announced Wednesday.
Watson Pharmaceuticals on Wednesday announced the sale of its Rugby over-the-counter business to the Harvard Drug Group — a distributor and provider of private-label OTCs and generic prescription products under the Major Pharmaceuticals brand — for approximately $117 million.
A Swiss subsidiary of drug maker Celgene Corp. said its chemotherapy drug produced "significant" improvement in progression-free survival in patients with a deadly skin cancer that had spread elsewhere in the body.
As many as 97% of parents are confident they administered the correct dose of acetaminophen to their sick child when using AccuDial Pharmaceutical's weight-based dosing label, according to research published earlier this year.
Watson Pharmaceuticals and Actavis will have to divest rights to almost two dozen drugs as a condition for U.S. regulatory approval of their $5.6 billion merger announced earlier this year, according to regulatory documents.
An uptick in the use of cholesterol drugs since the late 1980s and changes in Americans' diets may account for a fall in cholesterol levels, according to a new study by the Centers for Disease Control and Prevention.